Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Evotec
Evotec
Activities:
Research & Development
Cleaning
Pharmaceutical
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Titian and Evotec sign three-year agreement for sample management platform
The two companies have entered into an agreement that means Titian's software user licences can enable rapid deployment across new Evotec stites
Pharmaceutical
Evotec agrees to give US Merck access to facility of the future
MSD has paid $15m to gain access to Just–Evotec Biologics’ J.POD Washington facility that conducts small, intensified bioprocessing operations housed inside autonomous cleanrooms
Finance
Evotec acquires US biotech Just Biotherapeutics for $90 million
The US$90 million for the German company to make the acquisition includes the potential performance-based earn-out components expected within the next three years
Research & Development
Pharma giants join £9.5 million dementia drug discovery collaboration
Johnson & Johnson Innovation, Takeda and Evotec have joined The Dementia Consortium
Research & Development
Galapagos expands fibrosis portfolio
Fibrosis small molecule programme has been announced as the focus of a partnership between Galapagos and Evotec
Research & Development
Evotec and ABIVAX collaborate to develop novel antiviral agents
Evotec and ABIVAX have announced a strategic collaboration to discover and develop novel treatments for multiple viral infectious diseases
Media
Evotec to acquire Aptuit, expanding leadership in external innovation
Evotec and Aptuit have entered into a definitive agreement, Evotec will acquire Aptuit for US$ 300 million
Subscribe now